A Portfolio of Promise

Throughout our heritage, we have continued our commitment to innovation, with a focus for the past 5 years on developing our own product candidates in neurology and psychiatry.

The Supernus Pharmaceuticals Pipeline of Novel CNS Products

NDA=New Drug Application; IND=Investigational New Drug (application). ADHD=attention-deficit hyperactivity disorder;